Skip to main content
Log in

Oblimersen plus carboplatin and etoposide promising in small-cell lung cancer

  • Clinical study
  • Published:
Inpharma Weekly

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oblimersen plus carboplatin and etoposide promising in small-cell lung cancer. Inpharma Wkly. 1434, 10 (2004). https://doi.org/10.2165/00128413-200414340-00030

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-200414340-00030

Keywords

Navigation